Skip to main content

GALECTIN THERAPEUTICS INC

For the period ended Mar 31, 2025. Filed May 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 15, 2025

GALT$3.14+5.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Index

PART I — FINANCIAL INFORMATIONPAGE
ITEM 1. · Unaudited Condensed Consolidated Financial Statements (unaudited)
Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 20242
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 20243
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 20244
Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Deficit for the three months ended March 31, 2025 and 20245
Notes to Unaudited Condensed Consolidated Financial Statements6
ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations18
ITEM 3.Quantitative and Qualitative Disclosures about Market Risk26
ITEM 4.Controls and Procedures27
PART II — OTHER INFORMATION
ITEM 1.Legal Proceedings27
ITEM 1A.Risk Factors27
ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds27
ITEM 3.Defaults Upon Senior Securities27
ITEM 4.Mine Safety Disclosures27
ITEM 5.Other Information27
ITEM 6.Exhibits27
SIGNATURES29

Index

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.